Cargando…

Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three‐month prospective study

Detalles Bibliográficos
Autores principales:	Ghazanfar, Misbah Noshela, Bartko, Ewa Anna, Arildsen, Nicolai Skovbjerg, Poulsen, Lars K., Jensen, Bettina Margrethe, Enevold, Christian, Holm, Jesper Grønlund, Woetmann, Anders, Ødum, Niels, Thomsen, Simon Francis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311165/ https://www.ncbi.nlm.nih.gov/pubmed/35278253 http://dx.doi.org/10.1111/cea.14121

Ejemplares similares

Biomarkers for Monitoring Treatment Response of Omalizumab in Patients with Chronic Urticaria
por: Pedersen, Nadja Højgaard, et al.
Publicado: (2023)

Successful and Safe Treatment of Chronic Spontaneous Urticaria with Omalizumab in a Woman during Two Consecutive Pregnancies
por: Ghazanfar, Misbah Nasheela, et al.
Publicado: (2015)

Risk of comorbidities in patients diagnosed with chronic urticaria: A nationwide registry-study
por: Ghazanfar, Misbah Noshela, et al.
Publicado: (2020)

Occurrence and risk factors of mental disorders in patients with chronic urticaria
por: Ghazanfar, Misbah Noshela, et al.
Publicado: (2023)

Elevated, FcεRI‐dependent MRGPRX2 expression on basophils in chronic urticaria
por: Bartko, Ewa A., et al.
Publicado: (2022)

Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature
por: Ghazanfar, Misbah Nasheela, et al.
Publicado: (2015)

Expression of CCR8 and CCX-CKR on Basophils in Chronic Urticaria Is Amplified by IgE-Mediated Activation
por: Bartko, Ewa A., et al.
Publicado: (2023)

OMALIZUMAB IN TREATMENT-RESISTANT CHRONIC SPONTANEOUS URTICARIA
por: Godse, Kiran V
Publicado: (2011)

Profile of omalizumab in the treatment of chronic spontaneous urticaria
por: Labrador-Horrillo, Moises, et al.
Publicado: (2015)

Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy
por: Liao, Shuang-Lu, et al.
Publicado: (2021)

Omalizumab's efficacy and safety against chronic spontaneous urticaria
por: Özdemir, Öner
Publicado: (2023)

Omalizumab for Chronic Urticaria: A Case Series and Overview of the Literature
por: Ivyanskiy, Ilya, et al.
Publicado: (2012)

Omalizumab for chronic urticaria in Latin America
por: Wilches, Paul, et al.
Publicado: (2016)

Urticaria and angioedema as possible reactions of omalizumab
por: Ozbagcivan, Ozlem, et al.
Publicado: (2018)

Simvastatin is a potential candidate drug in ovarian clear cell carcinomas
por: Arildsen, Nicolai Skovbjerg, et al.
Publicado: (2020)

Omalizumab in chronic spontaneous urticaria (CSU): experience in three cases
por: Valle, Solange Oliveira Rodrigues, et al.
Publicado: (2015)

Omalizumab is effective in the treatment of difficult-to-treat chronic spontaneous urticaria
por: Forgie, Jennifer, et al.
Publicado: (2014)

Use of biologics in chronic spontaneous urticaria – beyond omalizumab therapy?
por: Metz, Martin, et al.
Publicado: (2021)

Sex differences in the efficacy of omalizumab in the treatment of chronic spontaneous urticaria
por: Sirufo, Maria Maddalena, et al.
Publicado: (2022)

Omalizumab treatment for chronic spontaneous urticaria: data from Turkey
por: Kara, Rabia Oztas, et al.
Publicado: (2022)

Cost‐effectiveness of personalized omalizumab dosing for chronic spontaneous urticaria
por: Denman, Sarah, et al.
Publicado: (2022)

Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both
por: Chen, Yudi, et al.
Publicado: (2021)

The impact of home treatment and self-administration of omalizumab on chronic urticaria
por: Wiuff, Anne Christine, et al.
Publicado: (2022)

Prospective, monocentric, observational study of the long-term effectiveness of omalizumab in chronic urticaria
por: Traidl, Stephan, et al.
Publicado: (2023)

High‐dose non‐sedating antihistamines are used insufficiently in chronic urticaria patients treated with omalizumab
por: Madsen, Hanne, et al.
Publicado: (2021)

269 Refractory Chronic Urticaria Treated with Omalizumab
por: Saenz, Martinez, et al.
Publicado: (2012)

Incapacitating solar urticaria: successful treatment with omalizumab
por: Kieselova, Katarina, et al.
Publicado: (2019)

Efficacy and safety of omalizumab therapy in urticaria vasculitis
por: Petrelli, Fiorella, et al.
Publicado: (2022)

Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
por: Metz, Martin, et al.
Publicado: (2020)

Position statement for the use of omalizumab in the management of chronic spontaneous urticaria in Indian patients
por: Godse, Kiran, et al.
Publicado: (2016)

Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Common Variable Immunodeficiency
por: Comberiati, Pasquale, et al.
Publicado: (2019)

Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria
por: Graham, Jonathan, et al.
Publicado: (2016)

Improving of psychological status and inflammatory biomarkers during omalizumab for chronic spontaneous urticaria
por: Diluvio, Laura, et al.
Publicado: (2020)

Response of FcεRI‐bearing leucocytes to omalizumab in chronic spontaneous urticaria
por: Alizadeh Aghdam, Mehran, et al.
Publicado: (2020)

Exploring Machine Learning Techniques to Predict the Response to Omalizumab in Chronic Spontaneous Urticaria
por: Sardina, Davide Stefano, et al.
Publicado: (2021)

Omalizumab Reduces Unplanned Healthcare Interactions in Irish Patients With Chronic Spontaneous Urticaria
por: Ridge, Katie, et al.
Publicado: (2021)

The course of COVID-19 in patients with chronic spontaneous urticaria receiving omalizumab treatment
por: Atayik, E., et al.
Publicado: (2022)

Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia
por: García-Gómez, Elizabeth, et al.
Publicado: (2022)

Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
por: Casale, Thomas B., et al.
Publicado: (2023)

Case report: Severe chronic spontaneous urticaria successfully treated with omalizumab and dupilumab
por: Puxkandl, Viktoria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f1imtjqavqq9rf54a5lkau7abj